RC
OGN icon

RegentAtlantic Capital’s Organon & Co OGN Stock Holding History

RegentAtlantic Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,156
Closed -$275K – 688
2022
Q2 		$275K Sell
8,156
-171
-2% -$5.99K 0.01% 565
2022
Q1 		$291K Sell
8,327
-992
-11% -$33.9K 0.01% 577
2021
Q4 		$284K Sell
9,319
-252
-3% -$8.21K 0.01% 587
2021
Q3 		$314K Sell
9,571
-1,642
-15% -$52.5K 0.01% 547
2021
Q2 		$339K Buy
+11,213
New +$369K 0.01% 504

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RegentAtlantic Capital's OGN Position: Q3 2022 in Review

RegentAtlantic Capital sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 8,156 shares — an estimated $275K sold.

RegentAtlantic Capital first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $339K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • RegentAtlantic Capital reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • RegentAtlantic Capital sold 8,156 Organon & Co shares in Q3 2022, an estimated $275K.
  • RegentAtlantic Capital first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • RegentAtlantic Capital's Organon & Co position peaked at $339K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.